Upcoming Pharma Surge in Germany: Sanofi's €1.3 Billion Insulin Manufacturing Investment in Frankfurt 💉

Sanofi is considering a €1.3–€1.5 billion investment to upgrade its insulin manufacturing site in Frankfurt, choosing Germany over relocating production to France. This move comes amid a wave of pharmaceutical investments in Germany, including Daiichi Sankyo's €1 billion cancer research facility near Munich and Eli Lilly's €2.5 billion injectable drug site in Rhineland-Palatinate. These projects reflect growing confidence in Germany's industrial and healthcare landscape despite economic challenges like inflation and rising living costs. Sanofi’s Q1 2024 sales surge of 6.7%, driven by products like Dupix

October 2026

S

M

T

W

T

F

S

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31